A new angiogenesis inhibitor targeting multiple tyrosine kinases offers new hope for treating tumors
BioMed Central blog,
A guest blog from co-Editor-in-Chief of Vascular Cell, Jan Kitajewski, in which he discusses the potential of using the newly…